The largest database of trusted experimental protocols

51 protocols using cd40l

1

B cell stimulation and IL-10 response

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cell number was counted by hemacytometer. Each 1×106 B cells were cultured in 200 μL IMDM+GlutaMAXTM (Life Technologies, Carlsbad, CA, USA) complete medium (contains 10% FCS, 100 U/mL penicillin, 100 mg/mL streptomycin, 2 mM L-glutamine, 2.5 μg/mL Amphotericin B and 50 μM 2-ME) in 96-well plates under the following conditions: control, CD40L, CD40L+LPS, CD40L+CpG, or CD40L+LPS+CpG in the absence or in the presence of fixed P. gingivalis. Final concentrations of these stimulants were as follows: CD40L (eBioscience, San Diego, CA, USA, 1 μg/mL), P. gingivalis LPS (Invivogen, San Diego, CA, USA, 10 μg/mL), mouse CpG-DNA (Hycult, Plymouth Meeting, PA, USA, 10 μM), and fixed P. gingivalis (5×106/1×106 cells). P. gingivalis LPS was used as TLR4 agonist and mouse CpG-DNA(5’-TCCATGACGTTCCTGATGCT -3’) was used as TLR9 agonist. B cells cultured without stimulation were used as control. Cells were cultured in a humidified incubator at 37°C with 5% CO2 for 48 h. Thirty of 200 μL medium in each well was used to determine CD1dhighCD5+ B cell percentages and remaining cells were used to determine IL-10 mRNA expression levels. Culture supernatant was used for secreted IL-10 levels measurement.
+ Open protocol
+ Expand
2

Activation and Tracking of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs from the Red Cross cohort were thawed and incubated with CFSE (Life Technologies, Carlsbad, CA) for 10 min as per manufacturer’s instructions. 5 mL of FBS (Gemini Bioproducts, West Sacramento, CA) was added and cells were incubated on ice for 5 min. Cells were rinsed and cultured with 10 μg/mL (Invivogen, San Diego, CA), 10 μg/mL CD40L (Invitrogen, San Diego, CA) and 2.5 ng/mL rhIL-21(Thermo Fisher Scientific), or CpG with CD40L and rhIL-21 similar to conditions described by Marasco et al. [11 (link)]. Controls with no stimuli, no CFSE, and anti-CD3/CD28 beads (Thermo Fisher Scientific) were included with each culture. Cells were then surface stained and acquired via flow cytometry using the Fortessa flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
3

Induction of Enteric Glial Cell Sepsis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce the cell sepsis model, EGCs were stimulated by single lipopolysaccharide (LPS) (10 μg/mL, E. coli O111:B4, Sigma-Aldrich, St. Louis, MO, USA), CD40L (1 μg/mL, PeproTech, Rocky Hill, NJ, USA) or LPS + CD40L. After 24 h, the cell culture supernatants were collected as EGCs-conditioned medium for cytokine measurement and Caco-2 cell treatment.
For the siRNA transfection, CD40-siRNA, TRAF6-siRNA, negative control siRNA (NC-siRNA), and siRNA-Mate transfection reagent were purchased from GenePharma Co. Ltd, (Shanghai, China). EGCs were transfected with CD40-siRNA, TRAF6-siRNA or NC-siRNA using siRNA-Mate according to the manufacturer’s protocols for 72 h before LPS and CD40L stimulation.
+ Open protocol
+ Expand
4

Induction of Enteric Glial Cell Sepsis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce the cell sepsis model, EGCs were stimulated by single lipopolysaccharide (LPS) (10 μg/mL, E. coli O111:B4, Sigma-Aldrich, St. Louis, MO, USA), CD40L (1 μg/mL, PeproTech, Rocky Hill, NJ, USA) or LPS + CD40L. After 24 h, the cell culture supernatants were collected as EGCs-conditioned medium for cytokine measurement and Caco-2 cell treatment.
For the siRNA transfection, CD40-siRNA, TRAF6-siRNA, negative control siRNA (NC-siRNA), and siRNA-Mate transfection reagent were purchased from GenePharma Co. Ltd, (Shanghai, China). EGCs were transfected with CD40-siRNA, TRAF6-siRNA or NC-siRNA using siRNA-Mate according to the manufacturer’s protocols for 72 h before LPS and CD40L stimulation.
+ Open protocol
+ Expand
5

Activation of Naïve B Cells into Plasmablasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
For 24 or 48 h cultures, PBMC was thawed and stimulated with IL-21 (50 ng/mL) (Miltenyi) with and without CD40L (5 μg/mL) (Peprotech). Four hours prior to harvest, brefeldinA/monensin were added to the cultures. Cells were harvested and stained for flow cytometry.
For plasmablast cultures, naïve B cells were isolated using the human naïve B cell isolation kit II (Miltenyi) and purity was assessed following 12-day cultures. Samples with purity >90% were plated at two million cells per well and cultured with IL-21 (15 pg/mL or 50 ng/mL) (Miltenyi) and CD40L (5 μg/mL) (Peprotech).
+ Open protocol
+ Expand
6

CD40L Stimulation for B Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All antibodies used are listed in Ting Information Table S1. Pacific Blue and Alexa 750 dyes used for barcoding (6 ) were from Molecular Probes. rhCD40L was from Peprotech (0.05 μg/ml) or Enzo Life Siences (0.25 μg/ml). CD40L from Enzo is fused to a FLAG® tag and was pre-incubated for 30 min with an Enhancer for ligands (anti-FLAG antibody; 1 μg/ml) to enhance the biological activity, according to manufacturer’s recommendations. CD40L from Enzo was used at a saturating concentration which potently induces proliferation and plasma cell differentiation in vitro when combined with IL-21 (Supporting Information Fig. S1). CD40L from Peprotech gave similar signaling responses without crosslinking (Supporting Information Fig. S2). CD40L from Enzo was used for Figure 2 and 4, CD40L from Peprotech was used for Figure 3.
+ Open protocol
+ Expand
7

Splenocyte Activation Assay with CD40L and LPS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were euthanized in a CO2 chamber and single-cell suspensions of splenocytes were obtained by dispersing spleen tissues through a 60-gauge stainless steel screen. Erythrocytes were removed by ACK lysing buffer (Lonza, MA). Isolated splenocytes were added into 96-well plates (2.0 × 105/well) in 200 µl RPMI complete medium containing 10% FBS. CD40L (Thermo Scientific) and E. coli LPS (strain O55:B5, Sigma-Aldrich) were used as agonist. Splenocytes from WT and TLR4−/− mice were divided into 4 treatment groups: control; E. coli LPS (10 µg/ml); CD40L (1 µg/ml); E. coli LPS (10 µg/ml) + CD40L (1 µg/ml). Cells were cultured at 37°C in a humidified incubator with 5% CO2 for 2 days and then were collected for analysis.
+ Open protocol
+ Expand
8

Flow Cytometry of CD40 Activated PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh human PBMCs were cultured with different concentrations of MAB273, CP-870,893 or CD40L (ThermoFisher, 34-8902-81) for 20 min at 4 °C and were then washed with cold PBS prior to incubation with 1 μg/mL CD40L-biotin (ThermoFisher, 15836427) for 20 min at 4 °C. Cells were washed with cold PBS and LIVE/DEAD staining as well as cell surface staining with a panel of fluorescently labeled antibodies was performed as described above (Table S1). After staining and washing, PBMCs were resuspended in 1% PFA and acquired on an LSRFortessa flow cytometer.
+ Open protocol
+ Expand
9

Lentiviral Transduction of Splenocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 1 × 106 splenocytes were stimulated with 5 µg/mL of LPS (InvivoGen) for 2 or 4 d in complete culture medium composed of Roswell Park Memory Institute medium (RPMI) supplemented with 10% fetal calf serum (Sigma), 0.05 mM 2-mercaptoethanol, 100 U/mL penicillin–streptomycin, 1 mM sodium pyruvate, and 0.1 mM nonessential amino acids (Gibco). Where indicated, cells were treated with 20 μM M1 and 10 μM Mdivi (Sigma) for 2 d from day 2 to day 4.
Stx5a-specific shRNAs were designed thanks to the RNAi consortium (https://portals.broadinstitute.org/gpp/public) and cloned in the pLKO.3G (Addgene #14748) vectors. Lentiviral particles were produced in the Human Embryonic Kidney 293T (HEK293T) cell line with the psPAX2 (Addgene #12260) and pMD2.G (Addgene #12259) vectors. For primary cell transduction, splenocytes were put in culture in complete culture medium in the presence of 80 ng/mL CD40L (Thermo Scientific) and 1 U/mL interleukin-4 (Miltenyi) for 24 h to promote B cell entry into cycle. The cells were then washed and transduced with lentiviral particles together with polybrene. After 24 h, cells were washed and differentiated into PCs by addition of LPS as indicated above.
+ Open protocol
+ Expand
10

Autologous T-cell Response Assay to Tumor-Loaded DCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Autologous mixed leukocyte reactions (MLRs) were performed to assay T-cell responses to DC that had been antigen-loaded by phagocytosis during co-culture with irradiated tumor cells (TC). Autologous PBMC were co-cultured with autologous TC or autologous DCV at PBMC:DCV and PBMC:TC ratios of 3:1 (6 million PBMC to 2 million antigen-loaded DC, or 6 million PBMC to 2 million TC) on a 6-well ultra-low attachment plate. The co-cultures were incubated at 37°C and 5% CO2 for 6 days. On day-6, the PBMCs were re-challenged with another 2 million TC or 2 million antigen-loaded DC, respectively. The co-cultures were analyzed by flow cytometry on day 12. Control MLR groups included PBMC alone, non-antigen-loaded DC, PBMCs treated with phorbol-12-myristate-13-acetate (PMA, 50 ng/ml, Sigma-Aldrich, St. Louis, MO) and ionomycin (1 μg/ml, Sigma-Aldrich, St. Louis, MO), PBMCs co-cultured with antigen-loaded DC in the presence of costimulatory molecule CD40L (500 ng/ml, Thermo Fisher Scientific, Waltham, MA) and anti-human CD28/CD49d antibodies (500 ng/ml, BD Biosciences, San Jose, CA), and PBMCs co-cultured with antigen-loaded DC in the presence of anti-IL-12 antibody (LEAF, 100 μg/ml, BioLegend, San Diego, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!